Switch to:
Array BioPharma Inc (NAS:ARRY)
Beneish M-Score
-6.91 (As of Today)

The zones of discrimination for M-Score is as such:

An M-Score of less than -2.22 suggests that the company is not an accounting manipulator.
An M-Score of greater than -2.22 signals that the company is likely an accounting manipulator.

Array BioPharma Inc has a M-score of -6.91 suggests that the company is not a manipulator.

ARRY' s 10-Year Beneish M-Score Range
Min: -7.32   Max: 349.55
Current: -6.91

-7.32
349.55

During the past 13 years, the highest Beneish M-Score of Array BioPharma Inc was 349.55. The lowest was -7.32. And the median was -2.62.


Definition

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Z-Score) or business trend (F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Array BioPharma Inc for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 0.9356+0.528 * -6.1458+0.404 * 1.9475+0.892 * 0.6047+0.115 * 0.849
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 1.8459+4.679 * -0.0976-0.327 * 1.0243
=-6.91

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

This Year (Jun14) TTM:Last Year (Jun13) TTM:
Accounts Receivable was $5.43 Mil.
Revenue was 6.011 + 7.773 + 14.066 + 14.228 = $42.08 Mil.
Gross Profit was -5.43 + -2.983 + 0.956 + 3.57 = $-3.89 Mil.
Total Current Assets was $121.68 Mil.
Total Assets was $139.05 Mil.
Property, Plant and Equipment(Net PPE) was $8.16 Mil.
Depreciation, Depletion and Amortization(DDA) was $4.51 Mil.
Selling, General & Admin. Expense(SGA) was $21.91 Mil.
Total Current Liabilities was $52.73 Mil.
Long-Term Debt was $103.95 Mil.
Net Income was -28.237 + -24.932 + -16.408 + -15.68 = $-85.26 Mil.
Non Operating Income was 0 + 0 + 0 + 0 = $0.00 Mil.
Cash Flow from Operations was -22.238 + -15.129 + -33.203 + -1.112 = $-71.68 Mil.
Accounts Receivable was $9.60 Mil.
Revenue was 25.415 + 9.955 + 18.377 + 15.833 = $69.58 Mil.
Gross Profit was 18.409 + 1.331 + 10.468 + 9.294 = $39.50 Mil.
Total Current Assets was $121.31 Mil.
Total Assets was $135.99 Mil.
Property, Plant and Equipment(Net PPE) was $10.05 Mil.
Depreciation, Depletion and Amortization(DDA) was $4.35 Mil.
Selling, General & Admin. Expense(SGA) was $19.63 Mil.
Total Current Liabilities was $50.58 Mil.
Long-Term Debt was $99.02 Mil.



1. DSRI = Days Sales in Receivables Index

Measured as the ratio of days’ sales in receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(5.429 / 42.078) / (9.595 / 69.58)
=0.12902229 / 0.13789882
=0.9356

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(-2.983 / 69.58) / (-5.43 / 42.078)
=0.56772061 / -0.09237606
=-6.1458

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than plant, property and equipment to total assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (121.676 + 8.157) / 139.053) / (1 - (121.309 + 10.049) / 135.988)
=0.06630565 / 0.03404712
=1.9475

4. SGI = Sales Growth Index

Ratio of sales in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=42.078 / 69.58
=0.6047

5. DEPI = Depreciation Index

Measured as the ratio of the rate of depreciation in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(4.35 / (4.35 + 10.049)) / (4.506 / (4.506 + 8.157))
=0.30210431 / 0.35583985
=0.849

6. SGAI = Sales, General and Administrative expenses Index

The ratio of SGA expenses in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(21.907 / 42.078) / (19.625 / 69.58)
=0.52062836 / 0.28204944
=1.8459

7. LVGI = Leverage Index

The ratio of total debt to total assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase$sgai= in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((103.952 + 52.733) / 139.053) / ((99.021 + 50.577) / 135.988)
=1.12680057 / 1.10008236
=1.0243

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(-85.257 - 0 - -71.682) / 139.053
=-0.0976

An M-Score of less than -2.22 suggests that the company will not be a manipulator. An M-Score of greater than -2.22 signals that the company is likely to be a manipulator.

Array BioPharma Inc has a M-score of -6.91 suggests that the company will not be a manipulator.


Related Terms

Altman Z-Score, Piotroski F-Score, Accounts Receivable, Revenue, Gross Profit, Total Current Assets, Total Assets, Property, Plant and Equipment, Depreciation, Depletion and Amortization, Selling, General & Admin. Expense, Total Current Liabilities, Long-Term Debt, Net Income, Non Operating Income, Cash Flow from Operations


Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

Array BioPharma Inc Annual Data

Jun05Jun06Jun07Jun08Jun09Jun10Jun11Jun12Jun13Jun14
DSRI 0.48192.0209240.9641011110.92090.9356
GMI -0.4251.36771.25971.25910.43270.79340.83611.2595-6.1458
AQI 0.0369023.0071.26090.5170.2710.7721.26581.9475
SGI 1.30650.98890.77920.86722.15681.33451.18410.81730.6047
DEPI 0.93720.82110.97750.94830.87450.69911.10270.98060.849
SGAI 0.89491.48771.46651.33280.44050.71170.78961.57951.846
LVGI 0.88381.58181.89172.91330.96161.50510.86210.70751.0243
TATA -0.0474-0.1499-0.2985-0.1803-0.60620.15760.10090.2671-0.0976
M-score -4.00-2.76225.35-4.81-4.68-2.00-1.937.97-6.91

Array BioPharma Inc Quarterly Data

Mar12Jun12Sep12Dec12Mar13Jun13Sep13Dec13Mar14Jun14
DSRI 1111110.92111110.9356
GMI 0.82160.83610.9091.03631.26571.25951.39071.70171.6873-6.1458
AQI 0.88360.7721.14630.55880.95091.26581.82612.9032.88641.9475
SGI 1.17921.18411.04390.89960.77620.81730.86220.86050.94840.6047
DEPI 0.68211.10271.13861.15911.18920.98060.91930.85880.80970.849
SGAI 0.78860.78960.99141.21871.61811.57961.42811.42031.191.8459
LVGI 0.82650.86211.02890.54461.00260.70750.53260.8470.78981.0243
TATA 0.03660.1010.440.31320.2940.26710.07960.07160.0004-0.0976
M-score -2.23-1.93-0.36-1.13-1.277.97-1.62-1.17-1.38-6.91
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK